Blood online
Home About Blood Authors Subscriptions Permission Advertising Public Access contact us
 

 
Advanced
Current Issue
First Edition
Future Articles
Archives
Submit to Blood
Search
American Society of Hematology
Meeting Abstracts
Email Alerts
Blood, 15 April 2004, Vol. 103, No. 8, pp. 3185-3191.
Prepublished online as a Blood First Edition Paper on December 11, 2003; DOI 10.1182/blood-2003-09-3022.


This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
2003-09-3022v1
103/8/3185    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Right arrow Rights and Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Matsunaga, T.
Right arrow Articles by Kurosawa, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Matsunaga, T.
Right arrow Articles by Kurosawa, H.
Related Collections
Right arrowRelated Article in Blood Online
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Submitted September 3, 2003
Accepted December 3, 2003

Regulation of annexin II by cytokine-initiated signaling pathways and E2A-HLF oncoprotein

Takayuki Matsunaga, Toshiya Inaba, Hirotaka Matsui, Mayuko Okuya, Atsushi Miyajima, Takeshi Inukai, Tetsunori Funabiki, Mikiya Endo, A Thomas Look, and Hidemitsu Kurosawa*

Department of Pediatrics, Dokkyo University School of Medicine, Tochigi, Japan
Department of Molecular Oncology, Research Institute for Radiation Biology and Medicine, Hiroshima University, Hiroshima, Japan
Institute of Molecular and Cellular Bioscience, The University of Tokyo, Tokyo, Japan
Department of Pediatrics, Yamanashi University, Yamanashi, Japan
Department of Pediatrics, Yokohama City University, Yokohama, Japan
Department of Pediatrics, Iwate Medical University, Iwate, Japan
Pediatric Oncology Department, Dana-Farber Cancer Institute, Boston, MA, USA

* Corresponding author; email: hidekuro{at}dokkyomed.ac.jp.

In pro-B cell acute lymphoblastic leukemia (ALL), expression of the E2A-HLF fusion gene as a result of the t(17;19)(q22;p13) is associated with poor prognosis, hypercalcemia, and hemorrhagic complications. We previously reported that the E2A-HLF fusion protein protects interleukin (IL)-3-dependent lymphoid cells from apoptosis caused by cytokine starvation. Here, we report that annexin II, a surface phospholipid-binding protein and one of the proposed causes of the hemorrhagic complications of acute promyelocytic leukemia (APL), is also implicated in t(17;19)+ ALL. Annexin II was expressed at high levels in APL cells and in each of four t(17;19)+ leukemia cell lines, and annexin II expression was induced by enforced expression of E2A-HLF in leukemia cells. In IL-3-dependent cells, we found that annexin II expression was regulated by IL-3 mainly by Ras pathways, including Ras/phosphatidylinositol 3-kinase pathways. Moreover, E2A-HLF increased annexin II expression in IL-3-dependent cells in the absence of the cytokine. These findings indicate that E2A-HLF induces annexin II by substituting for cytokines that activate downstream pathways of Ras.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?

Related Article in Blood Online:

"Annexing" acute leukemias
Kevin S. Smith
Blood 2004 103: 2869-2870. [Full Text] [PDF]



This article has been cited by other articles:


Home page
Mol. Biol. CellHome page
C.-Y. Wang, Y.-S. Lin, W.-C. Su, C.-L. Chen, and C.-F. Lin
Glycogen Synthase Kinase-3 and Omi/HtrA2 Induce Annexin A2 Cleavage followed by Cell Cycle Inhibition and Apoptosis
Mol. Biol. Cell, October 1, 2009; 20(19): 4153 - 4161.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
T. Inukai, T. Inaba, J. Dang, R. Kuribara, K. Ozawa, A. Miyajima, W. Wu, A. T. Look, Y. Arinobu, H. Iwasaki, et al.
TEF, an antiapoptotic bZIP transcription factor related to the oncogenic E2A-HLF chimera, inhibits cell growth by down-regulating expression of the common {beta} chain of cytokine receptors
Blood, June 1, 2005; 105(11): 4437 - 4444.
[Abstract] [Full Text] [PDF]



 click for free articles
home about blood authors subscriptions permissions advertising public access contact us
  Copyright © 2003 by American Society of Hematology         Online ISSN: 1528-0020